Defendant

Handa Pharma, Inc.

1 case as defendant.

Cases
1
Active
1
0 closed
Filed
Top venue
D. Delaware
1 case

Novartis Pharmaceuticals Corp. v. Handa Neuroscience, LLC et al.

Discovery active through mid-2022; final disposition unverified
Docket:
1:21-cv-00645

Suit against Handa entities asserting the '405 patent and also US 10,543,179. Handa sought summary judgment on the '405 patent after the Federal Circuit's June 2022 invalidation; final disposition not verified.